Valiant Laboratories Complete Financial Statements
VALIANTLAB • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for Valiant Laboratories (VALIANTLAB).
Downloads include all available records across all periods.
For market performance, see the
VALIANTLAB stock price today
.
Profitability Ratios
EBITDA Margin
2.13%
2025 data
Balance Sheet Ratios
Current Ratio
1.80
2025 data
Debt to Equity
1.71
2025 data
Equity Ratio
58.35%
2025 data
Asset Turnover
0.12
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+88.0%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+133.3%
Year-over-Year
Expense Growth
+64.3%
Year-over-Year
Assets Growth
+16.9%
Year-over-Year
Equity Growth
-1.3%
Year-over-Year
Liabilities Growth
+16.9%
Year-over-Year
Operating Cash Flow Growth
-50.0%
Year-over-Year
Investing Cash Flow Growth
+63.2%
Year-over-Year
Financing Cash Flow Growth
-70.4%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Jun 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47 | 56 | 48 | 25 | 33 | 22 | 37 | 63 | 92 | 54 | 42 | 84 | 72 |
| Expenses | 46 | 54 | 44 | 28 | 35 | 21 | 35 | 61 | 81 | 48 | 47 | 79 | 61 |
| EBITDA | 1 | 2 | 3 | -3 | -2 | 0 | 2 | 2 | 10 | 6 | -5 | 4 | 11 |
| Operating Profit Margin % | 0.00% | 7.00% | 5.00% | -31.00% | -15.00% | -13.00% | 2.00% | -2.00% | 10.00% | 7.00% | -16.00% | 5.00% | 14.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 3 | -4 | -3 | 0 | 2 | 1 | 10 | 6 | -5 | 4 | 10 |
| Tax | 0 | 0 | 1 | 1 | -1 | 0 | -1 | 0 | 2 | 2 | -2 | 1 | 3 |
| Net Profit | 0 | 1 | 2 | -5 | -1 | -1 | 2 | 1 | 8 | 4 | -4 | 3 | 8 |
| Earnings Per Share (₹) | 0.04 | 0.16 | 0.42 | -1.09 | -0.33 | -0.13 | 0.54 | 0.24 | 2.41 | 1.31 | -0.81 | 1.65 | 4.70 |
Related Pages for Valiant Laboratories
Additional stock information and data for VALIANTLAB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 401 | 343 | 213 |
| Current Assets | 193 | 226 | 151 |
| Fixed Assets | 48 | 50 | 48 |
| Capital Work in Progress | 156 | 43 | 1 |
| Investments | 0 | 38 | 34 |
| Other Assets | 197 | 212 | 130 |
| LIABILITIES | |||
| Total Liabilities | 401 | 343 | 213 |
| Current Liabilities | 107 | 77 | 62 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 234 | 237 | 101 |
| Share Capital | 44 | 44 | 33 |
| Reserves & Surplus | 191 | 193 | 68 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | 1 | 2 | 56 |
| Investing Activities | -53 | -144 | -55 |
| Financing Activities | 45 | 152 | -1 |
| Net Cash Flow | -7 | 11 | 0 |